1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,101 | 0,119 | 06.12. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Circio Holding ASA: Corr*: Atlas Holdings for CIRCIO | 2 | Oslo Børs | ||
| Mi | Circio Holding ASA: Atlas Holdings for CIRCIO | 8 | Oslo Børs | ||
| 24.11. | Circio Holding ASA: Circio presents data that further strengthens and broadens its circVec circular RNA expression platform | 2 | Oslo Børs | ||
| 19.11. | Circio Holding ASA: Atlas Holdings for CIRCIO | - | Oslo Børs | ||
| 19.11. | Circio Holding ASA: Shareholding Disclosure - Nordnet | 1 | Oslo Børs | ||
| 18.11. | Circio Holding ASA: Shareholding disclosure - Nordnet AB | 1 | Oslo Børs | ||
| 17.11. | Circio Holding ASA: Circio issues invitation to R&D and corporate update webcast on 24 November 2025 | 2 | Oslo Børs | ||
| 30.10. | Circio Holding ASA: Corr: Atlas Holdings for CIRCIO | 9 | Oslo Børs | ||
| CIRCIO Aktie jetzt für 0€ handeln | |||||
| 30.10. | Circio Holding ASA: Atlas Holdings for CIRCIO | 1 | Oslo Børs | ||
| 20.10. | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 1 | Oslo Børs | ||
| 15.10. | Circio Holding ASA: Requested Conversion of Convertible Bonds | 2 | Oslo Børs | ||
| 08.10. | Circio Holding ASA: Circio presents comprehensive circVec in vivo data package demonstrating 40-fold improvement over conventional AAV gene delivery at ESGCT 2025 | 3 | Oslo Børs | ||
| 06.10. | Circio Holding ASA: Requested Conversion of Convertible Bonds | 4 | Oslo Børs | ||
| 01.10. | Circio Holding ASA Approval and publication of prospectus for potential future share issues and conversion of convertible bonds | 3 | Oslo Børs | ||
| 01.10. | Circio Holding ASA: Circio to present comprehensive circVec-AAV in vivo data package at ESGCT 2025 | 9 | Oslo Børs | ||
| 09.09. | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 2 | Oslo Børs | ||
| 05.09. | Circio Holding ASA - Conversion of Convertible Bonds and funding requested under Additional Financing Commitment from Atlas | 1 | Oslo Børs | ||
| 28.08. | Circio 1H 2025 presentation: circVec technology shows 10-40x advantage in gene therapy | 3 | Investing.com | ||
| 04.08. | Circio Holding ASA Funding requested under additional financing commitment from Atlas | 1 | Oslo Børs | ||
| 07.07. | Circio Expands Laboratory Operations in Stockholm, Sweden | 8 | Contract Pharma |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOTEC | 5,454 | -2,57 % | Analyse und Ausblick: Evotec | ||
| MEDIGENE | 0,027 | -6,16 % | MEDIGENE AG stürzt ab - ich warne vor dem nächsten Desaster! | ||
| VALNEVA | 3,878 | +0,26 % | Valneva: Beim Kursziel der Aktie geht es nach oben | Im ersten Halbjahr 2026 soll es die Ergebnisse einer Phase-3-Studie von Valneva zu einem Impfstoff (VLA 15) gegen Lyme-Borreliose geben. In der Folge könnte bei positiven Ergebnissen die Zulassung in... ► Artikel lesen | |
| NOVAVAX | 5,875 | -0,93 % | Novavax, Inc. (NVAX): A Bull Case Theory | ||
| INOVIO PHARMACEUTICALS | 1,790 | 0,00 % | INOVIO Pharmaceuticals, Inc.: INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights | Completed rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review
Expect... ► Artikel lesen | |
| INFLARX | 0,933 | +1,03 % | Leerink Partners stuft Inflarx-Aktie wegen Finanzierungssorgen auf "Market Perform" herab | ||
| BAVARIAN NORDIC | 25,420 | 0,00 % | Bavarian Nordic A/S: Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million | COPENHAGEN, Denmark, December 2, 2025 - Bavarian Nordic A/S (OMX: BAVA) today announced its intent to launch a one-time share buy-back program of up to DKK 500 million to be executed over the next 12... ► Artikel lesen | |
| VAXART | 0,282 | 0,00 % | Vaxart, Inc.: Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results | Entered into an exclusive license agreement with Dynavax for the Company's COVID-19 oral pill vaccine candidate for potential cumulative proceeds of up to $700 million plus royalties Completed enrollment... ► Artikel lesen | |
| REDHILL BIOPHARMA | 1,185 | -1,25 % | RedHill Biopharma Ltd.: RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement | TEL-AVIV, Israel and RALEIGH, N.C., Dec. 1, 2025 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical... ► Artikel lesen | |
| EMERGENT BIOSOLUTIONS | 10,360 | +1,22 % | Emergent BioSolutions Reports Third Quarter 2025 Financial Results | Third Quarter 2025 Total Revenues of $231.1 million, above the high end of Q3 guidance by $21.0 millionThird Quarter 2025 Net Income of $51.2 million and Net Income Margin of 22%Third Quarter 2025... ► Artikel lesen | |
| TELIX PHARMACEUTICALS | 8,554 | +1,23 % | Telix Opens First Cyclotron Facility In Asia-Pacific | CANBERA (dpa-AFX) - Telix Pharmaceuticals Ltd. (TLX, TLPPF, TLX.AX), on Friday announced officially opened Telix Manufacturing Solutions in Yokohama, marking its first cyclotron facility in... ► Artikel lesen | |
| SINOVAC BIOTECH | - | - | Sinovac Biotech Ltd. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal | BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025, it received... ► Artikel lesen | |
| CYTOMX THERAPEUTICS | 3,434 | +1,36 % | CytomX Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of key data | ||
| AGENUS | 3,440 | +1,78 % | Agenus Inc.: Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances | France grants reimbursed access with patients having commenced treatment Two-year BOT/BAL survival presented at ESMO spanning more than five cancers in over 400 patients Phase 3 on... ► Artikel lesen | |
| NORTHWEST BIOTHERAPEUTICS | 0,190 | +3,26 % | Northwest Biotherapeutics, Inc.: Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility | BETHESDA, Md., Nov. 20, 2025 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax personalized immune therapies... ► Artikel lesen |
CIRCIO HOLDING ASA gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell -18,24 % bei einem Aktienkurs von 0,097 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CIRCIO HOLDING ASA finden Sie auf Wallstreet Online.